Healthcare / Medical Care FacilitiesHKSE
$0.08
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 19%
FCF escenarios
weak_data · normalized FCF $-3.8M · quality 51.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
26/100
D
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$90M
P/E
N/A
•EV/EBITDA
34.9x
↑ROE
155.6%
↑Gross Margin
51.9%
↑Debt/Equity
-1.62
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-33.3%
FCF CAGR
—
FCF margin
16.0%
FCF / Net income
-0.25x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $16.1M · net income $-10.1M · FCF $2.6M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $16.1M | $16.1M | $39.0M | $55.4M | $54.2M |
| Net Income | $-10.1M | $-10.1M | $-17.1M | $-5.9M | $-12.7M |
| EBITDA | $1.9M | $1.9M | $-10.1M | $1.8M | $4.4M |
| EPS | -0.01 | -0.01 | -0.02 | -0.01 | -0.02 |
| Gross Margin | 51.9% | 51.9% | 47.9% | 48.8% | 49.2% |
| Operating Margin | -67.5% | -67.5% | -26.0% | -17.7% | -61.7% |
| Net Margin | -62.8% | -62.8% | -43.9% | -10.6% | -23.4% |
| Balance Sheet | |||||
| Debt/Equity | -1.62 | -1.62 | 2.81 | 0.20 | 0.25 |
| Current Ratio | 10.27 | 10.27 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $2.6M | $2.6M | $-15.3M | $-3.8M | $-24.5M |
| Returns | |||||
| ROE | 155.6% | 155.6% | -392.7% | -26.5% | -42.9% |
| Valuation | |||||
| EV/EBITDA | 34.88 | 34.88 | — | 60.48 | 40.21 |
| P/B | — | — | 51.76 | 5.57 | 6.27 |
| Growth & Yield | |||||
| Revenue Growth | -58.6% | -58.6% | -29.6% | 2.1% | — |
| EPS Growth | 40.8% | 40.8% | -189.5% | 53.3% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+23.1%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.02 → -0.01
Residual
+23.1%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.